{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:35:25Z","timestamp":1790620525027,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cmi.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:36:07Z","timestamp":1548556567000},"page":"1157.e1-1157.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers"],"prefix":"10.1016","volume":"25","author":[{"given":"I.S.","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dhooria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.01.007_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.01.007_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.01.007_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.01.007_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/myc.12815","article-title":"Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis","volume":"61","author":"Sehgal","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.01.007_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12281-017-0304-7","article-title":"The management of chronic pulmonary aspergillosis: the UK national aspergillosis centre approach","volume":"11","author":"Maghrabi","year":"2017","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.cmi.2019.01.007_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.cmi.2019.01.007_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jac\/dkx390","article-title":"A\u00a0CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention","volume":"73","author":"Godet","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.01.007_bib8","first-page":"1","article-title":"Treatment of chronic pulmonary aspergillosis: current standards and future perspectives","author":"Alastruey-Izquierdo","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.cmi.2019.01.007_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.01.007_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/myc.12334","article-title":"Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis","volume":"58","author":"Agarwal","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.01.007_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01821-18","article-title":"Utility of serum and bronchoalveolar lavage fluid galactomannan in the diagnosis of chronic pulmonary aspergillosis","author":"Sehgal","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.01.007_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/myc.12541","article-title":"Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis","volume":"60","author":"Agarwal","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.01.007_bib13","article-title":"Is there an overlap in immune response between allergic bronchopulmonary and chronic pulmonary aspergillosis?","author":"Sehgal","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.cmi.2019.01.007_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"Bongomin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.01.007_bib15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/crj.12702","article-title":"Serum Aspergillus fumigatus-specific IgG antibody decreases after antifungal treatment in chronic pulmonary aspergillosis patients","volume":"12","author":"Yao","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.cmi.2019.01.007_bib16","first-page":"e133","article-title":"The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis","volume":"52","author":"Jain","year":"2006","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.01.007_bib17","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"Cadranel","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.01.007_bib18","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3389\/fmicb.2018.02223","article-title":"Evaluation of galactomannan testing, the aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"9","author":"Salzer","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2019.01.007_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/339324","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease","volume":"34","author":"Boutboul","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.01.007_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24022","article-title":"Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients","volume":"115","author":"Maertens","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2019.01.007_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/528715","article-title":"Aspergillus galactomannan index: a surrogate end point to assess outcome of therapy?","volume":"46","author":"Marr","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.01.007_bib22","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JCM.06513-11","article-title":"Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis","volume":"50","author":"Chai","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.01.007_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2018.06.001","article-title":"Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria","volume":"52","author":"Rodriguez-Goncer","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2019.01.007_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.01.007_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4ffcf1da-b180-4149-834c-9c723c5dbf9b","article-title":"Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19300278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19300278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:23Z","timestamp":1761117863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19300278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1198743X19300278"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.01.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}